Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stem Cells | 3 | 2020 | 3567 | 0.830 |
Why?
|
Immune Evasion | 3 | 2024 | 360 | 0.810 |
Why?
|
Hair Follicle | 2 | 2018 | 209 | 0.680 |
Why?
|
Bowman Capsule | 1 | 2018 | 1 | 0.670 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 93 | 0.600 |
Why?
|
Flow Cytometry | 4 | 2022 | 5974 | 0.600 |
Why?
|
Glomerulonephritis | 1 | 2018 | 372 | 0.550 |
Why?
|
Podocytes | 1 | 2018 | 396 | 0.480 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4479 | 0.460 |
Why?
|
Autoimmunity | 1 | 2020 | 1349 | 0.430 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 546 | 0.380 |
Why?
|
Intestines | 1 | 2020 | 1924 | 0.370 |
Why?
|
Dendritic Cells | 3 | 2018 | 2725 | 0.350 |
Why?
|
Lentivirus | 1 | 2012 | 501 | 0.350 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10180 | 0.340 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 592 | 0.330 |
Why?
|
Skin | 2 | 2020 | 4364 | 0.310 |
Why?
|
Prediabetic State | 1 | 2012 | 499 | 0.290 |
Why?
|
Tumor Escape | 2 | 2020 | 349 | 0.280 |
Why?
|
Islets of Langerhans | 1 | 2012 | 1352 | 0.270 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2538 | 0.260 |
Why?
|
Hepatocytes | 1 | 2012 | 1211 | 0.260 |
Why?
|
Mice, Transgenic | 6 | 2020 | 9734 | 0.260 |
Why?
|
Immunity, Innate | 2 | 2013 | 2958 | 0.250 |
Why?
|
SOXF Transcription Factors | 1 | 2024 | 29 | 0.240 |
Why?
|
Antigen Presentation | 5 | 2023 | 1284 | 0.230 |
Why?
|
Up-Regulation | 1 | 2012 | 4217 | 0.220 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2635 | 0.210 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3508 | 0.200 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5686 | 0.190 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 40 | 0.190 |
Why?
|
MicroRNAs | 2 | 2014 | 3752 | 0.190 |
Why?
|
Furans | 1 | 2021 | 194 | 0.180 |
Why?
|
Ketones | 1 | 2021 | 188 | 0.180 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2021 | 215 | 0.180 |
Why?
|
Receptors, Progesterone | 2 | 2021 | 1097 | 0.180 |
Why?
|
Phagocytes | 1 | 2021 | 297 | 0.170 |
Why?
|
Mice | 13 | 2024 | 81183 | 0.170 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3586 | 0.160 |
Why?
|
NF-kappa B | 2 | 2023 | 2499 | 0.150 |
Why?
|
Neoplasms | 2 | 2023 | 21683 | 0.150 |
Why?
|
Nuclear Transfer Techniques | 1 | 2017 | 64 | 0.150 |
Why?
|
Integrins | 1 | 2020 | 846 | 0.140 |
Why?
|
Receptors, Estrogen | 2 | 2021 | 2187 | 0.140 |
Why?
|
Poly I-C | 1 | 2016 | 115 | 0.140 |
Why?
|
Immunotherapy | 2 | 2022 | 4445 | 0.140 |
Why?
|
Integrin alpha Chains | 1 | 2016 | 97 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.130 |
Why?
|
Animals | 15 | 2024 | 168757 | 0.130 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 21827 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.120 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20822 | 0.120 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16689 | 0.120 |
Why?
|
Liver | 4 | 2014 | 7474 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2013 | 107 | 0.110 |
Why?
|
Mice, Knockout | 5 | 2018 | 14557 | 0.110 |
Why?
|
Adenoma | 1 | 2024 | 2174 | 0.110 |
Why?
|
Antigens | 1 | 2018 | 1466 | 0.110 |
Why?
|
Muscles | 1 | 2018 | 1614 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1988 | 0.110 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 561 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 695 | 0.110 |
Why?
|
Toll-Like Receptor 7 | 1 | 2013 | 172 | 0.110 |
Why?
|
Toll-Like Receptor 9 | 1 | 2013 | 212 | 0.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2016 | 491 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 2988 | 0.110 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2013 | 708 | 0.110 |
Why?
|
Mucopolysaccharidosis III | 1 | 2011 | 11 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2915 | 0.100 |
Why?
|
Nucleic Acids | 1 | 2013 | 182 | 0.100 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2416 | 0.100 |
Why?
|
Hydrolases | 1 | 2011 | 139 | 0.100 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2012 | 315 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2023 | 10481 | 0.090 |
Why?
|
Immunoblotting | 1 | 2013 | 1682 | 0.090 |
Why?
|
Gene Transfer Techniques | 2 | 2012 | 1224 | 0.090 |
Why?
|
DNA Replication | 1 | 2017 | 1399 | 0.090 |
Why?
|
Interferon-alpha | 1 | 2013 | 895 | 0.090 |
Why?
|
Point Mutation | 1 | 2014 | 1623 | 0.080 |
Why?
|
Hyperplasia | 1 | 2012 | 1185 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4149 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2133 | 0.080 |
Why?
|
Influenza, Human | 1 | 2019 | 1479 | 0.080 |
Why?
|
Insulin-Secreting Cells | 2 | 2012 | 891 | 0.080 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2969 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2012 | 1730 | 0.080 |
Why?
|
Hepacivirus | 1 | 2014 | 1379 | 0.070 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2012 | 1116 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2043 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.070 |
Why?
|
Fibrosis | 1 | 2012 | 2029 | 0.070 |
Why?
|
Antigens, CD | 1 | 2016 | 4026 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3920 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 2015 | 0.060 |
Why?
|
Hepatitis C | 1 | 2014 | 1591 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6773 | 0.060 |
Why?
|
Central Nervous System | 1 | 2011 | 1357 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2024 | 3206 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.060 |
Why?
|
Signal Transduction | 3 | 2021 | 23403 | 0.060 |
Why?
|
Humans | 15 | 2024 | 744343 | 0.060 |
Why?
|
Endoderm | 1 | 2024 | 154 | 0.060 |
Why?
|
Macrophages | 2 | 2021 | 5655 | 0.060 |
Why?
|
Cytokines | 2 | 2021 | 7322 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6622 | 0.050 |
Why?
|
Disease Progression | 2 | 2024 | 13284 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 2007 | 0.050 |
Why?
|
Taxoids | 1 | 2022 | 666 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2012 | 3864 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11366 | 0.040 |
Why?
|
Langerhans Cells | 1 | 2018 | 173 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1157 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 701 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3336 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Dermis | 1 | 2018 | 207 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 996 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2085 | 0.040 |
Why?
|
Interphase | 1 | 2017 | 226 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9438 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2012 | 19229 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5172 | 0.030 |
Why?
|
Genome, Human | 2 | 2021 | 4420 | 0.030 |
Why?
|
Influenza A virus | 1 | 2019 | 456 | 0.030 |
Why?
|
Female | 8 | 2023 | 380194 | 0.030 |
Why?
|
Chromosome Segregation | 1 | 2017 | 235 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1369 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2017 | 457 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 713 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1154 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1566 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1821 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1607 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9727 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
Chromatin | 1 | 2024 | 2934 | 0.030 |
Why?
|
Male | 4 | 2021 | 350118 | 0.030 |
Why?
|
Mitosis | 1 | 2017 | 1208 | 0.030 |
Why?
|
Gene Order | 1 | 2011 | 176 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2017 | 1701 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4851 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2011 | 552 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1149 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6386 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5882 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1420 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11725 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2011 | 913 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 29786 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2046 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 2307 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 16718 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 2432 | 0.020 |
Why?
|
Virus Replication | 1 | 2014 | 2534 | 0.020 |
Why?
|
Dependovirus | 1 | 2011 | 706 | 0.020 |
Why?
|
Lysosomes | 1 | 2011 | 893 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4409 | 0.020 |
Why?
|
Pancreatitis | 1 | 2012 | 1092 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4568 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.020 |
Why?
|
Cerebellum | 1 | 2011 | 1488 | 0.020 |
Why?
|
Visual Cortex | 1 | 2011 | 1149 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12797 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7722 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3420 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4931 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 213383 | 0.000 |
Why?
|
Adult | 1 | 2021 | 214055 | 0.000 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_